The valuation of Pharmeasy stands at a whopping $5 billion. The company has so far raised a total of $1.89 billion since 2015. The company is launching its IPO and aiming for a valuation of $7-8 billion.  There is also some news in the market that the company is about to raise $200 million at 15% lower valuation compared to last year which will dilute the valuation of the company to $3.8 billion.